In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

4th Annual Gene Therapy for Ophthalmic Disorders Summit

Oct 03, 2023 - 08:00 AM - Oct 05, 05:00 PM
Hanson Wade
The Westin Waltham Boston
70, 3rd Ave

ZIP: 02451
Phone: (+1) 617 455 4188

Ticket Price: USD 2599.00 - USD 5297.00

The 4th Annual Gene Therapy for Ophthalmic Disorders Summit is the industry-leading, industry-focused forum for learning how to validate novel administration routes to the eye, extrapolate effectively from preclinical models to inform safety and efficacy and define relevant endpoints for clinical trials.

Across 3 days of in-depth case studies, new data, and focused group discussions, hear from and engage with the likes of Janssen, Adverum Biotechnologies, Spark Therapeutics, SparingVision, AbbVie, and the RD Fund. As well as leveraging insights from these talks and panels: participate in breakout discussions, utilize Q and A time built into talks, and meet and learn from ophthalmic gene therapy leaders during our 5+ hours of dedicated networking time.

This Summit Will Bring Together Leading Voices on:

- Defining Relevant and Meaningful Endpoints
Investigate the latest trends in endpoint development and regulation, understand their applicability in animal model studies to clinical trials, and discuss the need for validated novel endpoints, with key insights from Adverum Biotechnologies and SparingVision.

- Levelling up the Translatability of Preclinical Models
Address the best practices in animal model selection and development, optimize the clinical relevancy of animal model studies, and leverage the latest retinal organoid developments, with expert sessions hosted by Atsena Therapeutics and MeiraGTx.

- Exploring Different Delivery Methods to the Front and Back of the Eye
Take a deep dive into the suprachoroidal route, overcome the AAV cargo capacity challenge with novel administration methods, and hear the latest updated on robotics-assisted subretinal delivery, with exciting discussions from Clearside Biomedical and Splice Bio.

- Understanding the Immune and Inflammatory Responses to Ocular Gene Therapies
How can improved promoters and enhancers deliver genes effectively without triggering the immune response? Which preclinical models are best suited to test the various variables associated with GTAU? What are the latest trends in immunosuppressant regimens being used in the field? Let AGTC and Kriya Therapeutics answer these questions, and many more.

- Leveraging Insights from Ophthalmology-Focused Venture Capital
Discover the current investment landscape for gene therapy in the ophthalmology field, and understand what venture capital investors are looking for when it comes to developing preclinical, clinical, and manufacturing packages in the most fruitful, cost-effective manner, with key insights from the RD Fund and Syncona.

Find out more in our event guide - https://ter.li/65eeyd

Tickets: https://go.evvnt.com/1799202-1?pid=1052

Speaker Details

Glenn Yiu, University of Calfornia Davis, Adam Turpcu, Adverum Biotechnologies, Daniel Chao, Janssen, Sarah Tuller, Opus Genetics, Sheila Nirenberg, Bionic Sight, Samarendra Mohanty, Nanoscope Therapeutics, Catherine Tsilfidis, Ottawa Hospital Research Institute, Adnan Dibas, Nanoscope Technologies, Jasmina Kapetanovic, University of Oxford, Constance Cepko, Harvard University, Melissa Calton, 4D Molecular Therapeutics, Ben Sajdak, Fauna Bio, Eva Andres-Mateos, Atsena Therapeutics, Arun Upadhyay, Ocugen, Jim Wang, Opus Genetics, Snehal Naik, Spark Therapeutics, Jed Chatterton, Spark Therapeutics, Tassos Georgiadis, MeiraGTx, Laura Moreno Leon, Iveric Bio, Simon Petersen-Jones, Michigan State University, Jie Shen, Abbvie, Todd Durham, Foundation Fighting Blindness, Karen Wagner, Ysios Capital Partners, Alicia Kemble, RD Fund, Christine Kay, Atsena Therapeutics, Viral Kansara, Clearside Biomedical, Gaurav Sahay, Oregon State University, Gerard Caelles, Splice Bio, Daniel Chung, SparingVision, Ash Jayagopal, Opus Genetics

Conference Only - Drug Developer: USD 2999.00,
Conference Only - Solution Provider: USD 3799.00,
Conference Only - Academic: USD 2599.00,
Conference + 1 Workshop - Drug Developer: USD 3648.00,
Conference + 1 Workshop - Solution Provider: USD 5297.00,
Conference + 1 Workshop - Academic: USD 3148.00,
Full Conference Access - Drug Developer: USD 4297.00,
Full Conference Access - Solution Provider: USD 5297.00,
Full Conference Access - Academic: USD 3697.00

Event Categories
Keywords: science , Conferences


Events Calendar

1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4


VIP Life Time Subscription to our Newsletters!